Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$751M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$692M |
| 3 |
Palantir
PLTR
|
+$434M |
| 4 |
Union Pacific
UNP
|
+$377M |
| 5 |
AbbVie
ABBV
|
+$367M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.74B |
| 2 |
Meta Platforms (Facebook)
META
|
+$602M |
| 3 |
Bank of America
BAC
|
+$600M |
| 4 |
Wells Fargo
WFC
|
+$568M |
| 5 |
Broadcom
AVGO
|
+$538M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.73% |
| 2 | Financials | 7.42% |
| 3 | Healthcare | 6.65% |
| 4 | Industrials | 6.3% |
| 5 | Consumer Discretionary | 5.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HEPS
4751
D-Market Electronic Services & Trading
HEPS
$1.05B
| $533K | ﹤0.01% |
197,363
+33,231
| +20% | +$90.2K |
|
|
SELX
4752
DELISTED
Semilux International
SELX
| $531K | ﹤0.01% |
418,418
-2,793
| -0.7% | -$4.07K |
|
|
EMX
4753
DELISTED
EMX Royalty
EMX
| $531K | ﹤0.01% |
210,740
+93,275
| +79% | +$210K |
|
4754
PUT
Viking Therapeutics
VKTX
$3.84B
| $530K | ﹤0.01% |
+20,000
| New | +$526K |
|
|
FBLA
4755
FB Bancorp
FBLA
$251M
| $530K | ﹤0.01% |
47,111
-222,378
| -83% | -$2.46M |
|
4756
CytomX Therapeutics
CTMX
$686M
| $530K | ﹤0.01% |
233,339
-2,592,937
| -92% | -$4.18M |
|
4757
CALL
Urban Outfitters
URBN
$6.41B
| $530K | ﹤0.01% |
7,300
-16,100
| -69% | -$967K |
|
4758
PUT
Delek US
DK
$3.98B
| $530K | ﹤0.01% |
+25,000
| New | +$420K |
|
4759
Monopar Therapeutics
MNPR
$712M
| $529K | ﹤0.01% |
14,789
-45,578
| -76% | -$1.66M |
|
4760
Biote Corp
BTMD
$65.2M
| $529K | ﹤0.01% |
131,488
-67,200
| -34% | -$248K |
|
4761
Boston Omaha
BOC
$437M
| $529K | ﹤0.01% |
37,643
-35,421
| -48% | -$516K |
|
4762
OneSpaWorld
OSW
$2.69B
| $526K | ﹤0.01% |
25,797
+10,690
| +71% | +$196K |
|
4763
CALL
Playtika
PLTK
$1.52B
| $526K | ﹤0.01% |
111,200
+11,200
| +11% | +$55.1K |
|
|
CTNM
4764
Contineum Therapeutics
CTNM
$532M
| $526K | ﹤0.01% |
+132,378
| New | +$575K |
|
4765
Shore Bancshares
SHBI
$824M
| $525K | ﹤0.01% |
33,408
-106,856
| -76% | -$1.5M |
|
4766
CALL
Toll Brothers
TOL
$14.2B
| $525K | ﹤0.01% |
4,600
-4,300
| -48% | -$446K |
|
|
ELEV
4767
DELISTED
Elevation Oncology
ELEV
| $523K | ﹤0.01% |
+1,424,446
| New | +$475K |
|
4768
Northern Technologies International Corp
NTIC
$77.2M
| $521K | ﹤0.01% |
+70,347
| New | +$537K |
|
4769
RE/MAX Holdings
RMAX
$195M
| $520K | ﹤0.01% |
63,595
+34,075
| +115% | +$265K |
|
4770
Inogen
INGN
$175M
| $519K | ﹤0.01% |
73,843
-53,867
| -42% | -$362K |
|
4771
Petco
WOOF
$797M
| $519K | ﹤0.01% |
183,273
+22,019
| +14% | +$68.4K |
|
|
PLMKU
4772
Plum Acquisition Corp IV Unit
PLMKU
$169M
| $518K | ﹤0.01% |
50,000
-150,000
| -75% | -$1.54M |
|
4773
Beyond Meat
BYND
$274M
| $517K | ﹤0.01% |
148,094
-761,482
| -84% | -$2.21M |
|
4774
Accel Entertainment
ACEL
$1B
| $517K | ﹤0.01% |
43,903
-458,618
| -91% | -$5.12M |
|
4775
Patrick Industries
PATK
$2.87B
| $516K | ﹤0.01% |
5,591
-13,447
| -71% | -$1.14M |
|
Similar funds
Millennium Management's Q2 2025 Portfolio in Review
As of Q2 2025, Millennium Management held 6,516 positions worth $207B, up 10% from $188B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Millennium Management's Q2 2025 filing shows 738 new, 2,295 increased, 2,418 reduced and 712 closed positions. Its largest new stake was Bank of America Series L: 164,000 shares worth $197K. The largest sale was iShares Core S&P 500 ETF, an estimated $1.74B.
By sector, the portfolio is most concentrated in Technology at 8.7% of assets, up from 7.8% a quarter earlier, followed by Financials and Healthcare.
- Millennium Management's largest Q2 2025 buy was Bank of America Series L: 164,000 shares worth $197K.
- Millennium Management added most to Applovin in Q2 2025, an estimated $751M increase.
- Millennium Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.74B.
- Millennium Management fully exited Discover Financial Services in Q2 2025, selling an estimated $282M.
- Millennium Management's ten largest holdings make up 16% of its $207B portfolio in Q2 2025.
- Millennium Management opened 738 new positions and closed 712 in Q2 2025.
- Millennium Management's portfolio value rose 10% quarter-over-quarter to $207B.
Based on Millennium Management's 13F filing for Q2 2025, filed 14 Aug 2025.